Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma
Authors:
- Rei SuzukiRSRei Suzuki
- Hiroki IrieHIHiroki Irie
- Tadayuki TakagiTTTadayuki Takagi
- Mitsuru SugimotoMSMitsuru Sugimoto
- Naoki KonnoNKNaoki Konno
- Yuki SatoYSYuki Sato
- Ko WatanabeKWKo Watanabe
- Jun NakamuraJNJun Nakamura
- Shigeru MarubashiSMShigeru Marubashi
- Takuto HikichiTHTakuto Hikichi
- Hiromasa OhiraHOHiromasa Ohira
Open Access
- 12 October 2018
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 974
Abstract
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for mucinous cystic neoplasm of the pancreas carries a potential risk of inducing peritoneal tumor cell dissemination. We investigated the diagnostic yield and safety of EUS-FNA-based cytology of cells obtained from the pancreatic invasion site of intraductal papillary-mucinous neoplasm-derived adenocarcinoma (IPMC). We included 22 surgically resected IPMCs and 84 pancreatic ductal adenocarcinomas (PDACs). Among the IPMC cases, 14 did not undergo EUS-FNA before surgical resection. The diagnostic yield of EUS-FNA was compared between IPMC and PDAC. Additionally, prognosis (relapse-free and overall survival time after resection) and the rate of peritoneal dissemination were compared among IPMC with EUS-FNA, IPMC without EUS-FNA, and PDAC. A survival analysis was performed using the Kaplan-Meier method and log-rank test. (EUS-FNA diagnosis) There were no significant differences in the number of needle passages (PDAC 2.5 vs. IPMC 2.0 passages, P = 0.84) or puncture route (stomach/duodenum: 2/6 vs. 45/39, P = 0.29). However, the correct diagnosis rate was significantly higher in PDAC (92.9%) than in IPMC (62.5%) (P = 0.03). No procedure-related adverse events occurred. Peritoneal lavage cytology performed during the operation was negative in all cases. (Prognosis) Among IPMC with EUS-FNA, IPMC without EUS-FNA, and PDAC, there were no significant differences in relapse-free survival (21.0 vs. 22.4 vs. 12.5 months, respectively; P = 0.64) or overall survival time (35.5 vs. 53.1 vs. 35.9 months, respectively; P = 0.42), and peritoneal dissemination was detected during the observation period in 25%, 28.5%, and 21.4% cases, respectively (P = 0.82). Even though a correct diagnosis was more difficult to obtain in IPMC than in PDAC, IPMC allows specimens to be obtained without influencing the rate of recurrence and prognosis.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasmsMedicine, 2017
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreasPancreatology, 2017
- American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular dataGastrointestinal Endoscopy, 2016
- Comparison of the international consensus guidelines for predicting malignancy in intraductal papillary mucinous neoplasmsSurgery, 2016
- Diagnostic yield of EUS-FNA-based cytology distinguishing malignant and benign IPMNs: A systematic review and meta-analysisPancreatology, 2014
- Diagnostic yield of endoscopic retrograde cholangiopancreatography‐based cytology for distinguishing malignant and benign intraductal papillary mucinous neoplasm: Systematic review and meta‐analysisDigestive Endoscopy, 2014
- The Carcinoembryonic Antigen Level in Pancreatic Juice and Mural Nodule Size Are Predictors of Malignancy for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2012
- MUC1 Is a Useful Molecular Marker for Malignant Intraductal Papillary Mucinous Neoplasms in Pancreatic Juice Obtained From Endoscopic Retrograde PancreatographyPancreas, 2010
- Intraductal Papillary Mucinous Neoplasms of the Pancreas: Performance of Pancreatic Fluid Analysis for Positive Diagnosis and the Prediction of MalignancyAmerican Journal of Gastroenterology, 2008
- Guidelines and standards: Help or hindrance?Diagnostic Cytopathology, 1997